News >

Rapid Sequencing May Alleviate Sequencing Challenges in mCRPC

Jessica Hergert
Published: Friday, Mar 20, 2020

William Oh, MD

William Oh, MD
The optimal sequencing of therapies for patients with metastatic castration-resistant prostate cancer (mCRPC) has proven to be a significant clinical challenge following the approvals of additional agents, said William K. Oh, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication